NeuroMetrix (Nasdaq:NURO) announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,004,445. The patent covers novel technology that enhances DPNCheck® device performance by detecting and rejecting erroneous test conditions during nerve conduction studies. As quoted in the press release: This patent further strengthens the position of the Company in offering easy-to-use, automated … Continued